BNTX Competitors & Alternatives
Compare BioNTech SE with similar stocks in the same industry
Biotechnology
BNTX
Main Stock$89.67
Tradestie Score
63
Market Cap
$24.57B
Revenue Growth
-0.6%
Analyst Upside
+30.9%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INSM
Insmed, Inc.
|
$95.06
|
$31.13B | - | 52 | Compare |
|
GMAB
Genmab A/S ADS
|
$40.00
|
$19.56B | 31.2 | 37 | Compare |
|
INCY
Incyte Genomics Inc
|
$116.93
|
$16.93B | 14.5 | 77 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$63.75
|
$15.70B | 33.1 | 44 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.55
|
$15.22B | - | 50 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$242.99
|
$12.36B | 18.3 | 51 | Compare |
|
EXEL
Exelixis Inc
|
$65.31
|
$11.09B | 20.4 | 38 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$37.45
|
$10.76B | - | 54 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$202.63
|
$10.74B | - | 35 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$56.63
|
$10.53B | 149.2 | 67 | Compare |
More BNTX Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2836)
221 stocks in this industry